These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12762292)

  • 21. Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features.
    Beringer PM; Appleman MD
    Curr Opin Pulm Med; 2000 Nov; 6(6):545-50. PubMed ID: 11100967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
    Elborn JS; Hodson M; Bertram C
    J Cyst Fibros; 2009 May; 8(3):211-7. PubMed ID: 19372063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of infectious cystic fibrosis patients: results of a systematic review.
    Vonberg RP; Gastmeier P
    Infect Control Hosp Epidemiol; 2005 Apr; 26(4):401-9. PubMed ID: 15865277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas cepacia infection in cystic fibrosis.
    Smith DL; Smith EG; Gumery LB; Stableforth DE
    Lancet; 1992 Jan; 339(8787):252. PubMed ID: 1370564
    [No Abstract]   [Full Text] [Related]  

  • 28. Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens.
    Di Bonaventura G; Pompilio A; Crocetta V; De Nicola S; Barbaro F; Giuliani L; D'Emilia E; Fiscarelli E; Bellomo RG; Saggini R
    Future Microbiol; 2014; 9(12):1303-17. PubMed ID: 25517897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
    da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
    Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex.
    Dryahina K; Sovová K; Nemec A; Španěl P
    J Breath Res; 2016 Aug; 10(3):037102. PubMed ID: 27506232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW; Nguyen CD; Foster JM; Burns JL
    J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of contamination of single-patient-use nebulizers over time.
    Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
    Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.
    Caballero Jde D; del Campo R; Tato M; Gómez G de la Pedrosa E; Cobo M; López-Causapé C; Gómez-Mampaso E; Oliver A; Cantón R;
    BMC Microbiol; 2014 Dec; 14():335. PubMed ID: 25927861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory infections in patients with cystic fibrosis undergoing lung transplantation.
    Lobo LJ; Noone PG
    Lancet Respir Med; 2014 Jan; 2(1):73-82. PubMed ID: 24461904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection.
    Blanchard AC; Waters VJ
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S3-S12. PubMed ID: 36069904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial contamination in the environment of hospitalised children with cystic fibrosis.
    Ferroni A; Werkhauser-Bertrand A; Le Bourgeois M; Beauvais R; Vrielynck S; Durand C; Lenoir G; Berche P; Sermet-Gaudelus I
    J Cyst Fibros; 2008 Nov; 7(6):477-82. PubMed ID: 18550452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist.
    O'Malley CA
    Respir Care; 2009 May; 54(5):641-57. PubMed ID: 19393108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenging and emerging pathogens in cystic fibrosis.
    de Vrankrijker AM; Wolfs TF; van der Ent CK
    Paediatr Respir Rev; 2010 Dec; 11(4):246-54. PubMed ID: 21109184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.